MIRAOAB 25 S5

MIRAOAB 50 S5

Mirabegron Extended Release Tablets 50mg & Solifenacin Succinate 5mg Tablets

MIRAOAB 50 S5 is a combination medication, consisting of Mirabergron and Solifenacin, This combination is generally used for the treatment of Overactive Bladder.

INDICATION:

Eases the symptoms of overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination)

MECHANISM OF ACTION

Mirabegron is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. It prevents frequent, urgent or uncontrolled urination.

Solifenacin is an antimuscarinic. It also works by relaxing muscles of the urinary bladder. It is used to treat symptoms of an overactive bladder. These can include: a sudden and urgent need to pee (urinary urgency), needing to pee more often than usual (urinary frequency)

DOSAGE:

1 Tablet once daily or as directed by the Physician.

DOSE RANGE:

Mirabegron – The dose range varies from 25 to 50mg daily.

Solifenacin – 5 mg – 10 mg day.

Also available:
MIRAOAB 50 S5

Mirabegron Extended Release Tablets 50mg & Solifenacin Succinate 5mg Tablets